Phase II study of adriamycin (NSC-123127) in patients with metastatic melanoma.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis
D004317:Doxorubicin